U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840977) titled 'COLON ERDERLY LOW DOSE' on Feb. 18.

Brief Summary: In this prospective, retrospective observational study, the case series of patients undergoing first-line treatment for metastatic colorectal adenocarcinoma with doublet fixed-dose and reduced-dose chemotherapy in combination with full-dose monoclonal antibody in patients aged 70 years or older is collected.

Study Start Date: April 01

Study Type: OBSERVATIONAL

Condition: Colon Adenocarcinoma

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Matteo Clavarezza

Information provided by (Responsible Party): Matteo Clavarezza, Ente Ospedaliero Ospedali Galliera

Disclaimer: Curated b...